Discussion To the best of our knowledge, this is the first paper aiming at exploring, valuable insights into the characteristics, treatment experiences, and outcomes of a diverse cohort using GLP-1 agonists for weight management in Kingdom of Saudi Arabia over the last ten years
2021;41:e272e3
Glucagon-Like Peptide-1 Agonism : Retatrutide incorporates specific alpha-aminobutyric acid substitutions at critical nodes along its amino acid chain
Insufficient food depletes glycogen from muscle tissue, making muscles more prone to cramps
References Albrecht S, Jung S, Mller R, et al
Proteomics, immunofluorescence, and conditioned taste avoidance tests further characterized the systemic and cellular effects of the drug